D
Vor Biopharma Inc. VOR
$33.80 -$1.89-5.28% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 21.65M 26.46M 27.88M 29.14M 30.15M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 336.67M 122.15M 121.19M 118.00M 124.80M
Operating Income -336.67M -122.15M -121.19M -118.00M -124.80M
Income Before Tax -1.66B -118.60M -116.91M -112.46M -118.09M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -1.66K -118.60 -116.91 -112.46 -118.09
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -1.66B -118.60M -116.91M -112.46M -118.09M
EBIT -336.67M -122.15M -121.19M -118.00M -124.80M
EBITDA -332.09M -118.74M -117.66M -114.44M -121.20M
EPS Basic -273.27 -30.18 -34.03 -33.00 -34.77
Normalized Basic EPS -167.73 -18.86 -21.27 -20.63 -21.73
EPS Diluted -273.27 -30.18 -34.03 -33.00 -34.77
Normalized Diluted EPS -167.73 -18.86 -21.27 -20.63 -21.73
Average Basic Shares Outstanding 19.43M 16.58M 13.74M 13.63M 13.59M
Average Diluted Shares Outstanding 19.43M 16.58M 13.74M 13.63M 13.59M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --